BSE filing, NSE: KFBL. Summary written from the filing by ALFA Finder's alert engine.
Kothari Fermentation & Biochem Ltd: key numbers
- Share price
- ₹40.45
- Market cap
- ₹60.68 Cr
- Revenue (annual)
- ₹112.1 Cr
- Net profit (annual)
- ₹-2.99 Cr
- P/E (TTM)
- -28.6×Sector 26.8×
- Promoter holding
- 68.87%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kothari Fermentation & Biochem Ltd
All →Kothari Fermentation & Biochem Other Announcement
Kothari Fermentation & Biochem Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Kothari Fermentation & Biochem Partnership
KFBL signed a commercial tie-up with Oriental Yeast India Private Limited for yeast distribution, manufacturing, and technical support. No upfront consideration; no new entity formed.
Kothari Fermentation & Biochem Annual General Meeting
Kothari Fermentation & Biochem Ltd held its 36th Annual General Meeting on September 30, 2026, to transact various ordinary and special business items.
Kothari Fermentation & Biochem Management Change
Kothari Fermentation and Biochem Ltd announced the resignation of M/s. Arun K. Garg & Associates as the Internal Auditor, effective from September 25, 2026.
Kothari Fermentation & Biochem Annual General Meeting
Kothari Fermentation and Biochem Ltd issued the notice for its 36th AGM, scheduled for September 30, 2026. The meeting will also consider revised director remuneration resolutions.
Kothari Fermentation & Biochem Q1 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Kothari Fermentation & Biochem Ltd reported revenue from operations of ₹30.4 Cr (+27.7% YoY) and net profit of ₹0.1 Cr for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.